Net profit of Novo Nordisk 2009-2022

Published by
Matej Mikulic,
Feb 6, 2023
Net profits of Danish pharmaceutical company Novo Nordisk increased annually during the period from 2009 to 2022, although with a stagnation from 2016 to 2019. In 2009, the net profit was around 9.6 billion Danish kroner, and until 2022, this amount had increased to over 55 billion Danish kroner.

Net profit of Novo Nordisk from 2009 to 2022 (in million DKK)

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2023

Region

Denmark

Survey time period

2009 to 2022

Supplementary notes

This statistic was assembled from several annual reports.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in Denmark "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical industry in Denmark

Position within Europe

3

Overview

5

Key players

8

Patents and clinical trials

5

Export, sales, purchase

5

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in Denmark Global pharmaceutical industryPharmaceutical industry in the U.S.Pharmaceutical industry in the UKPharmaceutical market in Italy
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu